Jubilant Ingrevia Limited (JUBLINGREA.NS)
INR 800.95
(-4.21%)
INR 800.95
(-4.21%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 11.56 INR | -40.23% |
| 2022 | 19.34 INR | -35.49% |
| 2021 | 29.98 INR | 44.34% |
| 2020 | 20.77 INR | 199811.54% |
| 2019 | -0.01 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 3.73 INR | 21.9% |
| 2024 Q1 | 3.06 INR | 65.41% |
| 2023 Q2 | 3.62 INR | 0.0% |
| 2023 FY | - INR | -40.23% |
| 2023 Q4 | 1.85 INR | -23.87% |
| 2023 Q3 | 2.43 INR | -32.87% |
| 2023 Q1 | 3.62 INR | 10.37% |
| 2022 Q2 | 5.31 INR | 6.41% |
| 2022 Q1 | 4.99 INR | 15.78% |
| 2022 FY | - INR | -35.49% |
| 2022 Q4 | 3.28 INR | -42.96% |
| 2022 Q3 | 5.75 INR | 8.29% |
| 2021 FY | - INR | 44.34% |
| 2021 Q4 | 4.31 INR | -46.92% |
| 2021 Q3 | 8.12 INR | 16.5% |
| 2021 Q2 | 6.97 INR | -34.12% |
| 2021 Q1 | 10.58 INR | 209.36% |
| 2020 Q4 | 3.42 INR | 200.0% |
| 2020 Q3 | -3.42 INR | -132.39% |
| 2020 Q2 | 10.56 INR | 0.0% |
| 2020 FY | - INR | 199811.54% |
| 2019 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | -35.205% |
| Blue Jet Healthcare Limited | 9.44 INR | -22.458% |
| Concord Biotech Limited | 29.45 INR | 60.747% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 218.08% |
| Lyka Labs Limited | -0.75 INR | 1641.333% |
| Panacea Biotec Limited | -0.19 INR | 6184.211% |
| Piramal Pharma Limited | 0.14 INR | -8157.143% |
| SMS Lifesciences India Limited | 30.08 INR | 61.569% |
| Supriya Lifescience Limited | 14.80 INR | 21.892% |
| Syngene International Limited | 12.71 INR | 9.048% |
| TAKE Solutions Limited | -8.18 INR | 241.32% |
| Zota Health Care Limited | -5.55 INR | 308.288% |